These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2939698)

  • 21. Evidence for functional 5-HT2 receptor sites on human blood platelets.
    De Clerck F; Xhonneux B; Leysen J; Janssen PA
    Biochem Pharmacol; 1984 Sep; 33(17):2807-11. PubMed ID: 6466388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of ketanserin, a novel serotonergic receptor antagonist, on 5HT-induced shape change and 5HT uptake in rat and human platelets.
    Lampugnani MG; de Gaetano G
    Biochem Pharmacol; 1982 Sep; 31(18):3000-2. PubMed ID: 7138588
    [No Abstract]   [Full Text] [Related]  

  • 23. Serotonin-induced platelet aggregation predicts the antihypertensive response to serotonin receptor antagonists.
    Gleerup G; Persson B; Hedner T; Winther K
    Eur J Clin Pharmacol; 1993; 44(2):121-5. PubMed ID: 8453957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
    Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The sensitivity of human blood platelets to the aggregating agent ADP during different dietary sodium intakes in healthy men.
    Gow IF; Dockrell M; Edwards CR; Elder A; Grieve J; Kane G; Padfield PL; Waugh CJ; Williams BC
    Eur J Clin Pharmacol; 1992; 43(6):635-8. PubMed ID: 1493845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the serotonin antagonists, cyproheptadine, ketanserin and mianserin, on cyclic flow reductions in stenosed canine coronary arteries.
    Bush LR
    J Pharmacol Exp Ther; 1987 Feb; 240(2):674-82. PubMed ID: 3806419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of the new antimigraine drug serotonin receptor antagonist tropoxin on platelet aggregation].
    Vasil'eva TM; Petrukhina GN; Miftakhova NT; Makarov VA; Gan'shina TS; Bezhanian SG; Mirzoian RS
    Eksp Klin Farmakol; 2005; 68(3):30-3. PubMed ID: 16047677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketanserin (S2-receptor blocking agent), platelet activity and chronic alcoholism.
    Santini P; Ceccanti M; De Lorenzo A; Pisculli M; Di Giovanni MG; Cavaleri G; Attilia ML; Berbellini A
    Int J Clin Pharmacol Res; 1986; 6(1):73-6. PubMed ID: 2937746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ketanserin on platelet function and red cell filterability in hypertension and peripheral vascular disease.
    Zannad F; Voisin P; Pointel JP; Schmitt C; Freitag B; Stoltz JF
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S32-4. PubMed ID: 2412053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of binding indices and physiological responsiveness of the 5-HT2 receptor on human platelets.
    McBride PA; Mann JJ; Polley MJ; Wiley AJ; Sweeney JA
    Life Sci; 1987 May; 40(18):1799-809. PubMed ID: 3573979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of N-acetylglucosamine and platelet inhibitors on the synergistic interaction of platelets and aggregating agents in the presence of wheat germ agglutinin.
    Tandon NN; Ordinas A; Jamieson GA
    Biochim Biophys Acta; 1982 Nov; 719(2):388-95. PubMed ID: 6817815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of platelet aggregation in vitro by microbubbles of nitrogen.
    Thorsen T; Lie RT; Holmsen H
    Undersea Biomed Res; 1989 Nov; 16(6):453-64. PubMed ID: 2603242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of MDL 28,133A, a 5-HT2 receptor antagonist, on platelet aggregation and coronary thrombosis in dogs.
    Hsieh CP; Sakai K; Bruns GC; Dage RC
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):761-72. PubMed ID: 7532754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Collagen induced human platelet aggregation: serotonin receptor antagonism retards aggregate growth in vitro.
    Menys VC
    Cardiovasc Res; 1993 Nov; 27(11):1916-9. PubMed ID: 8287397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-Hydroxytryptamine2 (5-HT2) structure-function relationships of the nitro and amino phenylpiperazines on intact human platelets.
    VandenBerg SR; Britt SG; Redpath GT; Gonias SL
    Biochem Pharmacol; 1989 Dec; 38(23):4237-44. PubMed ID: 2597195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Covalent complexes of albumin with serotonin, ketanserin and lysergic acid antagonize the activity of serotonin in human platelets.
    VandenBerg SR; Gonias SL
    Life Sci; 1989; 44(23):1777-85. PubMed ID: 2733551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ketanserin on the hyperreactivity of platelets to 5-hydroxytryptamine in patients with cardiovascular diseases.
    De Cree J; Leempoels J; Demoen B; Roels V; Verhaegen H
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S26-8. PubMed ID: 2412051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [2-(omega-phenylalkyl)phenoxy]alkylamines.II: Synthesis and selective serotonin-2 receptor binding.
    Tanaka N; Goto R; Ito R; Hayakawa M; Sugidachi A; Ogawa T; Asai F; Fujimoto K
    Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):245-55. PubMed ID: 10705513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet hypersensitivity to serotonin after prolonged ketanserin intake?
    Arnout J; Van Russelt M; Deckmyn H; Vermylen J; Fiocchi R; Lijnen P; Amery A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S20-2. PubMed ID: 2412049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-vessel wall interactions: implication of 5-hydroxytryptamine. A review.
    De Clerck F; van Nueten JM; Reneman RS
    Agents Actions; 1984 Dec; 15(5-6):612-26. PubMed ID: 6397984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.